NEU1 antibody (AA 156-415)
Quick Overview for NEU1 antibody (AA 156-415) (ABIN6144538)
Target
See all NEU1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 156-415
-
Sequence
- SLCAHKAGCQ VASTMLVWSK DDGVSWSTPR NLSLDIGTEV FAPGPGSGIQ KQREPRKGRL IVCGHGTLER DGVFCLLSDD HGASWRYGSG VSGIPYGQPK QENDFNPDEC QPYELPDGSV VINARNQNNY HCHCRIVLRS YDACDTLRPR DVTFDPELVD PVVAAGAVVT SSGIVFFSNP AHPEFRVNLT LRWSFSNGTS WRKETVQLWP GPSGYSSLAT LEGSMDGEEQ APQLYVLYEK GRNHYTESIS VAKISVYGTL
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 156-415 of human NEU1 (NP_000425.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IHC,1:50 - 1:200
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NEU1 (Sialidase 1 (Lysosomal Sialidase) (NEU1))
-
Alternative Name
- NEU1
-
Background
- The protein encoded by this gene is a lysosomal enzyme that cleaves terminal sialic acid residues from substrates such as glycoproteins and glycolipids. In the lysosome, this enzyme is part of a heterotrimeric complex together with beta-galactosidase and cathepsin A (the latter is also referred to as 'protective protein'). Mutations in this gene can lead to sialidosis, a lysosomal storage disease that can be type 1 (cherry red spot-myoclonus syndrome or normosomatic type), which is late-onset, or type 2 (the dysmorphic type), which occurs at an earlier age with increased severity.,NEU1,NANH,NEU,SIAL1,Cancer,Signal Transduction,Endocrine & Metabolism,Amino acid metabolism,NEU1
-
Molecular Weight
- 45 kDa
-
Gene ID
- 4758
-
UniProt
- Q99519
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-